Kunkel Lori Anne bought ELVN
December 17, 2025 · Form 4 insider transaction
Kunkel Lori Anne bought 15,958 shares of Enliven Therapeutics, Inc. at $1.12 per share, a transaction worth $17.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,958
Price
$1.12
Total value
$17.9K
InsiderKunkel Lori Anne
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after30,712
OwnershipDirect
10b5-1 planNo
AmendedNo